| Consumer protection - 1980 - 468 pages
...is a 'new drug' within the meaningof 21 USC 321(p) and thus required premarketing approval of either a new drug application [NDA], or an abbreviated new drug application [ANDA], or a Notice of Claimed Investigational Exemption under 21 USC 355 in that NAS-NRC [National Academy... | |
| International Validation Forum - Science - 1995 - 1114 pages
...soon as possible. * PART I - BACKGROUND The Food, Drug, and Cosmetic Act provides that FDA may approve a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA) only if the methods used in, and the facilities and controls used for, the manufacture, processing,... | |
| Daryl S. Paulson - Science - 1999 - 228 pages
...straight-forward. For example, the product must be manufactured under Good Manufacturing Practices (GMPs), and laboratory testing of the product must be performed...filed. Regulatory agencies such as the FDA also require that a battery of specific tests be conducted. These include such things as clinical trials, time-kill,... | |
| Carmen Medina - Medical - 2003 - 604 pages
...number of different types of pharmaceutical applications that can be filed with the agency, such as a new drug application (NDA), or an abbreviated new drug application (ANDA). Changes to the manufacturing and analytical commitments made within these applications must be reported... | |
| Sarfaraz K. Niazi - Medical - 2004 - 256 pages
...generic drug industry. A. BACKGROUND The Food, Drug, and Cosmetic Act provides that the FDA may approve a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA) only if the methods used in, and the facilities and controls used for, the manufacture, processing,... | |
| C. Ralph Buncher, Jia-Yeong Tsay - Mathematics - 2005 - 512 pages
...Administration (FDA) requires that pharmaceutical companies perform these studies in order to produce a new drug application (NDA) or an abbreviated new drug application (ANDA). Specific details related to the requirements for an NDA are presented in the Federal Register (January... | |
| Smita Gopalaswamy, Venky Gopalaswamy - Medical - 2008 - 264 pages
...drug, device, and biologic products. Through the post-approval audits of approved products, whether a new drug application (NDA) or an abbreviated new drug application (ANDA), the FDA confirms that postmarketing compliance is met by approved manufacturing establishments to ensure... | |
| |